CD8+ T cells in cutaneous T-cell lymphoma: Expression of cytotoxic proteins, Fas ligand, and killing inhibitory receptors and their relationship with clinical behavior

Journal of Clinical Oncology

Volumn 19, Issue 23, 2001, Pages 4322-4329

  Vermeer, M H ^a   Doorn, R V ^a   Dukers, D ^a   Bekkenk, M W ^a   Meijer, C J L M ^a   Willemze, R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD158A ANTIGEN; CD158B ANTIGEN; CD30 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC FACTOR; FAS ANTIGEN; FAS LIGAND; GRANZYME B; KILLER CELL INHIBITORY RECEPTOR; T CELL RESTRICTED INTRACELLULAR ANTIGEN 1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SKIN LYMPHOMA; STAINING; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE SECTION; TUMOR BIOPSY;

EID: 0035576116     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.23.4322     Document Type: Article

References (37)

1. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
2. Mycosis fungoides disease evolution and prognosis of 309 Dutch patients
3. Use of biological response modifiers in the treatment of cutaneous T-cell lymphoma
4. The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens
5. Tumor-specific peptides in cutaneous T-cell lymphoma: Association with class I major histo-compatibility complex and possible derivation from the clonotypic T-cell receptor
6. Isolation of tumor-specific cytotoxic CD4+ and CD4+ CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma
7. Cutaneous T-cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Thl cytokine profile and use a fas-independent pathway for specific tumor cell lysis
8. Clinical implications of immunologic phenotyping in cutaneous T-cell lymphoma
9. CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides
10. Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity
11. Mechanisms of CD95 (APO-I/Fas) mediated apoptosis
12. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes
13. TIA-1 structural and functional studies on a new class of cytolytic effector molecule
14. Expression of perforin and granzymes in vivo: Potential diagnostic markers for activated cytotoxic cells
15. Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes
16. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells
17. Human natural killer cell receptor for HLA-class I molecules: Evidence that the Kp43 (CD94) molecule functions as a receptor for HLA-B allele
18. Human CDS+ T lymphocyte subsets that express HLA I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations
19. Functional inhibitory receptors expressed by a cutaneous T cell lymphomaspecific cytolytic clonal T cell population
20. Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B showing cross reactions with the natural proteins
21. Localization and identification of granzymes A- and B-expressing cells in normal human lymphoid tissue and peripheral blood
22. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease
23. Prognostic significance of Fas and Fas-ligand expression in cutaneous B-cell lymphomas
24. Activated cytotoxic T-cells as prognostic marker in Hodgkin's disease
25. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype
26. Ultrasensitive FISH using peroxidase-mediated deposition of biotin fluorochrome tyramides
27. A cytotoxic phenotype does not predict clinical outcome in anaplastic large-cell lymphomas
28. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease
29. Most primary cutaneous CD30 positive lymphoproliferative disorders have a CD4 positive cytotoxic T-cell phenotype
30. Mechanism and biological significance of CD4-mediated cytotoxicity
31. Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated: MHC-restricted cytotoxic T-lymphocyte phenotype
32. Primary cutaneous CD8-positive epidermotropic cytotoxic T-cell lymphomas: A distinctive clinicopathological entity with an aggressive behavior
33. Execution and suicide: Cytotoxic T cells enforce Draconian laws through separate molecular pathways
34. The cell biology of CTL killing
35. The role of granzyme B-expressing CD8-positive T cells in apoptosis of keratinocytes in lichen planus
36. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma: Association between lack of Fas expression and aggressive types of CTCL
37. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes